IEEE Spectrum on MSN
At-home brain stimulation for depression is just the start
Flow’s headset is the first tDCS device approved by the FDA ...
A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...
A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...
News Medical on MSN
Research reveals dual impact of brain stimulation on people with depression and anxiety
Research investigating the effects of transcranial direct current stimulation (tDCS) on individuals with depression and ...
The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...
A new study suggests that a promising noninvasive brain stimulation technique may not function exactly as psychiatrists had ...
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...
Amanda Ellison does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
A home-based brain stimulation device appeared to boost cognition in patients with early Alzheimer's disease (AD), although the effect was small, a new study showed. Patients who received active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results